“INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA” (2024) Journal of Population Therapeutics and Clinical Pharmacology, 31(9), pp. 1502–1518. doi:10.53555/68zhqm37.